Rare diseases
Investigational molecules
Locations
Back to Romania316 clinical trials in Craiova, Romania across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in RomaniaStudii.Clinice.ro(opens in a new tab)RomaniaStudy on Ifinatamab Deruxtecan and Topotecan for Patients with Relapsed Small Cell Lung Cancer
RomaniaStudy Comparing OSE2101 and Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Immunotherapy Resistance
RomaniaStudy on Efepoetin Alfa and Darbepoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis
RomaniaStudy on VE303 for Preventing Recurrent C. difficile Infection in Patients
RomaniaStudy on Long-Term Safety of KarXT (Trospium Chloride, Xanomeline Tartrate) for Patients with Alzheimer's-Related Psychosis
RomaniaStudy of BI-1206 and Pembrolizumab for Patients with Advanced Solid Tumors Previously Treated with Anti-PD-1 or Anti-PD-L1 Therapy
RomaniaStudy Comparing MK-5684 with Abiraterone Acetate or Enzalutamide for Patients with Advanced Prostate Cancer After Hormonal Therapy
RomaniaStudy of MK-1084 and Pembrolizumab for First-Line Treatment in Patients with Metastatic Non-Small Cell Lung Cancer with KRAS G12C Mutation and High PD-L1 Levels
RomaniaStudy on the Effectiveness and Safety of Selinexor for Patients with Myelofibrosis and Moderate Thrombocytopenia Who Have Not Used JAK Inhibitors
RomaniaStudy on THIO and Cemiplimab for Patients with Advanced Non-Small Cell Lung Cancer
RomaniaLong-term Safety Study of Niraparib for Patients with Advanced Ovarian, Breast, or Prostate Cancer Who Completed a Previous Niraparib Study
RomaniaThe busiest research cities in the country
What the registry says about research in the country
Current trials focus on innovative treatments for pulmonary conditions, including investigations into new therapies for asthma and pulmonary fibrosis. Research evaluates medication effectiveness in improving lung function and breathing capacity.
Studies incorporate both targeted therapies and combination treatments to address various stages of respiratory diseases.
Groundbreaking research in cancer treatment explores novel therapeutic approaches for various types of cancer, with particular focus on gastric, prostate, and lung cancers.
Trials evaluate combination therapies and immunotherapy approaches for improved patient outcomes.
Studies focus on preventing and treating heart failure and related conditions, with innovative approaches to cardiovascular disease management and metabolic disorders.
Research emphasizes both preventive strategies and treatment interventions for cardiovascular conditions.
Advanced research in autoimmune conditions and inflammatory disorders, investigating new therapeutic options for various immune-mediated diseases.
Studies evaluate both targeted therapies and broader immunological approaches.
Innovative research addressing neurological disorders and mental health conditions, with focus on both therapeutic interventions and disease management.
Trials explore novel treatment approaches for complex neurological and psychiatric conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
